Your Patients Can't Find Their Testosterone — Here's How You Can Help

Androgel availability issues have become a recurring concern in clinical practice. Your patients are calling your office, frustrated that their pharmacy can't fill their prescription. Some are going without their testosterone for days or weeks — disrupting the stable hormone levels you've worked to achieve.

As a prescriber, you're in a unique position to help. This guide offers a practical, step-by-step approach to helping your patients find Androgel in stock and maintain continuity of their testosterone replacement therapy during the current supply environment.

Current Availability: What You Need to Know

As of early 2026, the availability of Androgel and generic testosterone gel varies significantly across regions and pharmacy networks:

• Brand-name Androgel 1.62% (AbbVie): Still in production but pharmacy-level stock is inconsistent. Some pharmacies can special-order within 1-2 business days.
• Generic testosterone gel: Available from multiple manufacturers (Teva, Perrigo, and others) in both 1% and 1.62% strengths, but stock varies by wholesaler.
• Testosterone Cypionate injections: In intermittent shortage since 2023; improving but still unpredictable.
• Alternative gels (Testim, Fortesta): Generally more available than Androgel specifically.

The shortage is driven by manufacturer exits (including Actavis discontinuing its generic gel), rising TRT demand, and DEA Schedule III ordering constraints. For a detailed timeline, see our provider shortage briefing.

Why Patients Can't Find Androgel

Understanding the patient experience helps you anticipate and address their concerns:

Chain Pharmacy Limitations

Large chain pharmacies (CVS, Walgreens, Rite Aid) manage inventory centrally. When a testosterone product is allocated limited supply, individual stores may only receive enough for existing auto-refill patients — leaving new or transferred prescriptions unfilled.

Insurance Barriers

Prior authorization requirements add 1-5 business days between prescription and fill. If a PA is denied, patients may face a brand-name Androgel cost of $720-$1,100+ out of pocket — a price point that leads many to abandon the prescription entirely.

Controlled Substance Complications

As a Schedule III controlled substance, testosterone gel is subject to DEA ordering quotas. Pharmacies can't simply stockpile extra supply, and some are hesitant to carry large quantities of controlled substances due to regulatory scrutiny.

Patient Knowledge Gaps

Many patients don't know they can request a special order, try an independent pharmacy, or use tools like Medfinder to check stock. They assume that if one pharmacy is out, all pharmacies are out.

What Providers Can Do: 5 Actionable Steps

Step 1: Write Prescriptions to Maximize Fill Success

Simple prescribing practices can significantly improve your patients' chances of getting filled:

• Allow generic substitution unless there's a clinical reason for brand-only. Generic testosterone gel is more widely stocked and costs as little as $85/month with a coupon vs. $720+ for brand Androgel.
• Include both strengths in patient notes so that if 1.62% is unavailable, you can quickly switch to 1% with a dose adjustment.
• Send prescriptions electronically to the pharmacy with confirmed stock (Medfinder can help verify this in advance).

Step 2: Direct Patients to Medfinder

Medfinder for Providers is a free tool that shows real-time pharmacy availability for Androgel and other testosterone products by zip code. You can:

• Check stock before sending a prescription to a specific pharmacy
• Share the tool link with patients so they can check availability themselves
• Use it as part of your follow-up workflow when patients report fill issues

Step 3: Build Relationships with Independent Pharmacies

Independent pharmacies often have different wholesaler relationships than chain pharmacies, giving them access to stock that chains may not have. Identifying 2-3 independent pharmacies in your area that reliably carry testosterone products can be invaluable during shortage periods.

Compounding pharmacies are another resource. They can prepare testosterone gel preparations using USP-grade testosterone when manufactured products are unavailable. This requires a specific compounding prescription from your office.

Step 4: Proactively Prepare Alternative Prescriptions

Don't wait for the patient to call and report they can't fill their prescription. Consider having a backup plan documented in the chart:

• First alternative: Generic testosterone gel (same formulation, different manufacturer)
• Second alternative: Testim 1% or Fortesta 2% gel
• Third alternative: Androderm patch (good for patients concerned about gel transfer)
• Fourth alternative: Testosterone Cypionate injection (most affordable at $30-$50/month)

Having these options pre-identified speeds up the process when a patient calls.

Step 5: Help Patients Reduce Cost Barriers

Cost-related prescription abandonment is a significant issue with testosterone products. Equip your team with knowledge of available programs:

• AbbVie savings card: Up to $100/month off brand Androgel for commercially insured patients
• AbbVie Patient Assistance Foundation: Free Androgel for qualifying uninsured/underinsured patients (1-800-222-6885)
• Discount coupons: GoodRx, SingleCare, and other programs bring generic testosterone gel down to $85-$150/month
• 90-day fills: May reduce per-unit costs and ensure patients have a longer supply buffer

Share our patient-facing guide: How to Save Money on Androgel in 2026.

Alternatives at a Glance

When Androgel isn't available, here's a quick reference for alternative testosterone products:

• Testim (testosterone 1% gel): Applied to shoulders/upper arms. Tubes only, distinct scent. Available as generic.
• Fortesta (testosterone 2% gel): Applied to inner thighs via metered pump. Higher concentration = less gel. Available as generic.
• Androderm (testosterone patch): Applied nightly. No transfer risk. May cause skin irritation. 2 mg and 4 mg doses.
• Testosterone Cypionate injection: IM every 1-2 weeks. Most affordable. In intermittent shortage but improving. Requires patient education on self-injection.
• Jatenzo / Tlando (oral testosterone): Newer options that avoid skin transfer and injection. Typically require PA. Higher cost tier.

For detailed alternative comparisons, share Alternatives to Androgel with your patients.

Workflow Tips for Your Practice

• Add a flag in your EHR for patients on testosterone therapy during the shortage period so your team can proactively address fill issues at visits.
• Schedule follow-up labs 4-6 weeks after any formulation switch to verify testosterone levels remain in range.
• Document backup formulation preferences in the patient chart so that when a call comes in, your staff can act quickly without needing to page you.
• Batch prior authorizations: If multiple patients are on the same testosterone product, submit PAs proactively rather than waiting for pharmacy rejections.
• Share medfinder.com/providers with patients at the point of prescribing so they're empowered to check availability themselves.

Final Thoughts

The Androgel shortage requires a shift in how practices approach testosterone prescribing — from a "write and forget" model to a more proactive, patient-partnered approach. By leveraging tools like Medfinder for Providers, maintaining flexible prescribing strategies, and equipping patients with cost-saving resources, you can minimize treatment disruptions and maintain patient trust during a challenging supply environment.

For more clinical context on the shortage, review our companion article: Androgel Shortage: What Providers and Prescribers Need to Know in 2026. For guidance on helping patients with costs specifically, see How to Help Patients Save Money on Androgel: A Provider's Guide.